These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 28883730)

  • 1. Drug delivery approaches for breast cancer.
    Singh SK; Singh S; Lillard JW; Singh R
    Int J Nanomedicine; 2017; 12():6205-6218. PubMed ID: 28883730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotargeted agents: an emerging therapeutic strategy for breast cancer.
    Du M; Ouyang Y; Meng F; Ma Q; Liu H; Zhuang Y; Pang M; Cai T; Cai Y
    Nanomedicine (Lond); 2019 Jul; 14(13):1771-1786. PubMed ID: 31298065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in Nanoparticle-Based Targeted Drug-Delivery Systems Against Cancer and Role of Tumor Microenvironment.
    Ashfaq UA; Riaz M; Yasmeen E; Yousaf MZ
    Crit Rev Ther Drug Carrier Syst; 2017; 34(4):317-353. PubMed ID: 29199588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Update on Nanocarrier(s) as the Targeted Therapy for Breast Cancer.
    Mukherjee D; Raikwar S
    AAPS PharmSciTech; 2024 Jul; 25(6):153. PubMed ID: 38961013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano-pharmaceutical formulations for targeted drug delivery against HER2 in breast cancer.
    Sadat SM; Saeidnia S; Nazarali AJ; Haddadi A
    Curr Cancer Drug Targets; 2015; 15(1):71-86. PubMed ID: 25564255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on Nanotechnology-based Drug Delivery Systems in Cancer Treatment.
    Ho BN; Pfeffer CM; Singh ATK
    Anticancer Res; 2017 Nov; 37(11):5975-5981. PubMed ID: 29061776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy.
    Luo C; Sun J; Sun B; He Z
    Trends Pharmacol Sci; 2014 Nov; 35(11):556-66. PubMed ID: 25441774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology: An Emerging Therapeutic Option for Breast Cancer.
    Hussain Z; Khan JA; Murtaza S
    Crit Rev Eukaryot Gene Expr; 2018; 28(2):163-175. PubMed ID: 30055543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle-mediated targeted drug delivery for breast cancer treatment.
    Liyanage PY; Hettiarachchi SD; Zhou Y; Ouhtit A; Seven ES; Oztan CY; Celik E; Leblanc RM
    Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):419-433. PubMed ID: 31034927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor extracellular acidity-activated nanoparticles as drug delivery systems for enhanced cancer therapy.
    Du JZ; Mao CQ; Yuan YY; Yang XZ; Wang J
    Biotechnol Adv; 2014; 32(4):789-803. PubMed ID: 23933109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted drug delivery for breast cancer treatment.
    Jin S; Ye K
    Recent Pat Anticancer Drug Discov; 2013 May; 8(2):143-53. PubMed ID: 23394116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy.
    Raj S; Khurana S; Choudhari R; Kesari KK; Kamal MA; Garg N; Ruokolainen J; Das BC; Kumar D
    Semin Cancer Biol; 2021 Feb; 69():166-177. PubMed ID: 31715247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal Cancer Management by Herbal Drug-Based Nanocarriers: An Overview.
    Kulwal V; Baxi K; Sawarkar SP; Bhatt LK
    Crit Rev Ther Drug Carrier Syst; 2020; 37(1):65-104. PubMed ID: 32450014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. iRGD-modified lipid-polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability.
    Gao F; Zhang J; Fu C; Xie X; Peng F; You J; Tang H; Wang Z; Li P; Chen J
    Int J Nanomedicine; 2017; 12():4147-4162. PubMed ID: 28615942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
    Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z
    J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast Cancer Targeted Treatment Strategies: Promising Nanocarrier Approaches.
    Malliappan SP; Kandasamy P; Chidambaram S; Venkatasubbu D; Perumal SK; Sugumaran A
    Anticancer Agents Med Chem; 2020; 20(11):1300-1310. PubMed ID: 31642415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymeric nanoparticles for cancer therapy.
    Parveen S; Sahoo SK
    J Drug Target; 2008 Feb; 16(2):108-23. PubMed ID: 18274932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards a targeted multi-drug delivery approach to improve therapeutic efficacy in breast cancer.
    Wang B; Rosano JM; Cheheltani R; Achary MP; Kiani MF
    Expert Opin Drug Deliv; 2010 Oct; 7(10):1159-73. PubMed ID: 20738211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bufalin loaded biotinylated chitosan nanoparticles: an efficient drug delivery system for targeted chemotherapy against breast carcinoma.
    Tian X; Yin H; Zhang S; Luo Y; Xu K; Ma P; Sui C; Meng F; Liu Y; Jiang Y; Fang J
    Eur J Pharm Biopharm; 2014 Aug; 87(3):445-53. PubMed ID: 24846793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of nanotechnology for the treatment of cancer: Recent advances.
    Klochkov SG; Neganova ME; Nikolenko VN; Chen K; Somasundaram SG; Kirkland CE; Aliev G
    Semin Cancer Biol; 2021 Feb; 69():190-199. PubMed ID: 31446004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.